Trial ID or NCT#

NCT01970670

Status

RECRUITING

Purpose

The primary objective is to determine how accurately one can estimate the size of the index tumor on preoperative imaging in patients with known breast cancer, using pathology as a reference standard. The primary endpoint, which will be measured on CEDM,and CE-MRI, is the maximum diameter (mm) of the index tumor.

Official Title

Contrast-Enhanced Digital Mammography (CEDM) vs Contrast-Enhanced Breast MRI (CE-MRI) in Patients With Known Breast Cancer

Eligibility Criteria

Ages Eligible for Study: 18 Years to 70 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: No

Investigator(s)

Jafi Lipson
Radiologist, Diagnostic radiologist
Clinical Associate Professor, Radiology

Contact us to find out if this trial is right for you.

CONTACT

Sumita Sood
(650) 723-0618